期刊文献+

Genome-wide association studies - A summary for the clinical gastroenterologist

Genome-wide association studies - A summary for the clinical gastroenterologist
在线阅读 下载PDF
导出
摘要 Genome-wide association studies (GWAS) have been applied to various gastrointestinal and liver diseases in recent years. A large number of susceptibility genes and key biological pathways in disease development have been identified. So far, studies in inflammatory bowel diseases, and in particular Crohn’s disease, have been especially successful in def ining new susceptibility loci using the GWAS design. The identification of associations related to autophagy as well as several genes involved in immunological response will be important to future research on Crohn’s disease. In this review, key methodological aspects of GWAS, the importance of proper cohort collection, genotyping issues and statistical methods are summarized. Ways of addressing the shortcomings of the GWAS design, when it comes to rare variants, are also discussed. For each of the relevant conditions, fi ndings from the various GWAS are summarized with a focus on the affected biological systems. Genome-wide association studies (GWAS) have been applied to various gastrointestinal and liver diseases in recent years. A large number of susceptibility genes and key biological pathways in disease development have been identified. So far, studies in inflammatory bowel diseases, and in particular Crohn's disease, have been especially successful in defining new susceptibility loci using the GWAS design. The identification of associations related to autophagy as well as several genes involved in immunological response will be important to future research on Crohn's disease. In this review, key methodological aspects of GWAS, the importance of proper cohort collection, genotyping issues and statistical methods are summarized. Ways of addressing the shortcomings of the GWAS design, when it comes to rare variants, are also discussed. For each of the relevant conditions, findings from the various GWAS are summarized with a focus on the affected biological systems.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第43期5377-5396,共20页 世界胃肠病学杂志(英文版)
关键词 Genome-wide association studies Inflamma-tory bowel disease GASTROENTEROLOGY HEPATOLOGY 全基因组 胃肠病 关联 临床 肝脏疾病 生物系统 易感基因 免疫反应
  • 相关文献

参考文献2

二级参考文献143

  • 1S Desplat-Jégo,C Johanet,A Escande,J Goetz,N Fabien,N Olsson,E Ballot,J Sarles,JJ Baudon,JC Grimaud,M Veyrac,P Chamouard,RL Humbel.Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicent[J].World Journal of Gastroenterology,2007,13(16):2312-2318. 被引量:24
  • 2[3]Cullen SN,Chapman RW.Review article:current management of primary sclerosing cholangitis.Aliment Pharmacol Ther 2005; 21:933-948
  • 3[4]Olsson R,Boberg KM,de Muckadell OS,Lindgren S,Hultcrantz R,Folvik G,Bell H,Gangsoy-Kristiansen M,Matre J,Rydning A,Wikman O,Danielsson A,Sandberg-Gertzen H,Ung KA,Eriksson A,Loof L,Prytz H,Marschall HU,Broome U.High-dose ursodeoxycholic acid in primary sclerosing cholangitis:a 5-year multicenter,randomized,controlled study.Gastroenterology 2005; 129:1464-1472
  • 4[5]Brandsaeter B,Friman S,Broome U,Isoniemi H,Olausson M,Backman L,Hansen B,Schrumpf E,Oksanen A,Ericzon BG,Hockerstedt K,Makisalo H,Kirkegaard P,Bjoro K.Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries.Scand J Gastroenterol 2003;38:1176-1183
  • 5[6]Talwalkar JA,Lindor KD.Primary sclerosing cholangitis.Inflamm Bowel Dis 2005; 11:62-72
  • 6[7]Boberg KM,Aadland E,Jahnsen J,Raknerud N,Stiris M,Bell H.Incidence and prevalence of primary biliary cirrhosis,primary sclerosing cholangitis,and autoimmune hepatitis in a Norwegian population.Scand J Gastroenterol 1998; 33:99-103
  • 7[8]Kingham JG,Kochar N,Gravenor MB.Incidence,clinical patterns,and outcomes of primary sclerosing cholangitis in South Wales,United Kingdom.Gastroenterology 2004; 126:1929-1930
  • 8[9]Bambha K,Kim WR,Talwalkar J,Torgerson H,Benson JT,Therneau TM,Loftus EV Jr,Yawn BP,Dickson ER,Melton LJ 3rd.Incidence,clinical spectrum,and outcomes of primary sclerosing cholangitis in a United States community.Gastroenterology 2003; 125:1364-1369
  • 9[10]Schrumpf E,Boberg KM.Epidemiology of primary sclerosing cholangitis.Best Pract Res Clin Gastroenterol 2001; 15:553-562
  • 10[15]Podolsky DK.Inflammatory bowel disease.N Engl J Med 2002; 347:417-429

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部